Evaluated in a noninferiority study and an open-label extension study
Glucose and lipid levels evaluated in a noninferiority study
Incidence of extrapyramidal symptoms evaluated in a noninferiority study
Change in prolactin levels evaluated in a noninferiority study
Reference: 1. INVEGA HAFYERA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.